NCT05186649 is a clinical trial of WARFARIN in Left Atrial Appendage Aneurysm, sponsored by University of Karachi.

Who is sponsoring NCT05186649?

NCT05186649 is sponsored by University of Karachi.

What drugs are being tested in NCT05186649?

Interventions in NCT05186649: WARFARIN.

What condition does NCT05186649 study?

NCT05186649 studies Left Atrial Appendage Aneurysm, Mitral Stenosis.

Is NCT05186649 still recruiting?

NCT05186649 is currently status unknown. Last updated 11 January 2022.

Last reviewed 2022-01-11 · How we verify

NCT05186649

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis

Status unknown Last updated 11 January 2022

What this trial tests

trial testing WARFARIN in Left Atrial Appendage Aneurysm in 52 participants. Status unknown.

Timeline

1 December 2021

Primary endpoint
30 June 2022

15 July 2022

Quick facts

Lead sponsor	University of Karachi
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	52
Start date	1 December 2021
Primary completion	30 June 2022
Estimated completion	15 July 2022
Sites	1 location across Pakistan

Drugs / interventions tested

WARFARIN (warfarin) — full drug profile →

Conditions studied

Left Atrial Appendage Aneurysm — all drugs for Left Atrial Appendage Aneurysm →
Mitral Stenosis — all drugs for Mitral Stenosis →

Sponsor

University of Karachi

Who can join

Adults 18 to 65, any sex, with Left Atrial Appendage Aneurysm or Mitral Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Consecutive patients with severe mitral stenosis and clot in left atrial appendage (LAA) on transesophageal echocardiography fulfilling the inclusion criteria will be recruited for this study. An ACUSON 128-XP echocardiographic system equipped with omniplane and biplane transesophageal probes will be used for this study. TEE followed by CT Angiography will be performed according to the standard procedure after obtaining informed consent.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Karachi trials

Trials by the same sponsor.

NCT07496099 — Effects of Post-Isometric Relaxation and Myofascial Release on Low Back Pain With Lower Cross Syndrome · NA · not yet recruiting
NCT07396233 — Effects of Diagonal Proprioceptive Neuromuscular Facilitation Patterns on Pain and Functional Outcomes in Patients With · NA · recruiting
NCT07332845 — Symmetrical Scapula-pelvis Proprioceptive Neuromuscular Facilitation and Superficial Back Line in Chronic Neck Pain With · NA · recruiting
NCT07205042 — Walking for Hypothyroidism Trial (WHT) · NA · not yet recruiting
NCT06960330 — Wearable Biofeedback Devices for Remote Physiotherapy and Rehabilitation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05186649 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Karachi
Last refreshed: 11 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05186649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing